Brief: Bio-Rad Q4 Sales USD 693.2 Million Vs. IBES Estimate USD 688.8 Million
12/02/2026 21:15
Feb 12 (Reuters) - Bio-Rad Q4 gross margin 49.8%. Q4 net income USD 720 million Q4 EPS USD 26.65 outlook FY adjusted revenue growth 0.5-1.5%
Recent news on Bio-Rad Laboratories
See all newsBio-Rad Laboratories, Inc. reports results for the quarter ended June 30 - Earnings Summary
Brief: Bio-Rad Laboratories On July 31, Initiated Restructuring Plan - SEC Filing
Bio-Rad Q2 revenue beats analyst estimates on clinical diagnostics growth
Brief: Bio-Rad Q2 Net Income USD 371.4 Million
Activist investors make bigger push for campaigns in H1, seek more M&A